13F-HR filed by Freestone Capital Holdings, LLC
Freestone Capital Holdings, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 508 holding rows worth $2,366,607,000.
- Accession
- 0001172661-22-000540
- Filer
- CIK 1470876
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 508 entries on the cover page, a total value of $2,366,607,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,366,607,000 with VALUE read as thousands by filing date, 13F file number 028-13894. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFREESTONE CAPITAL MANAGEMENT LLC028-05975
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GREENLANE HLDGS INC | 395330103 | CL A | 30,160 | $29,000 | thousands by filing date | |
| MIZUHO FINANCIAL GROUP INC SPONSORED ADR | 60687Y109 | ADR | 10,304 | $26,000 | thousands by filing date | |
| ATHERSYS INC | 04744L106 | COM | 25,000 | $23,000 | thousands by filing date | |
| ONCOCYTE CORP | 68235C107 | COM | 10,000 | $22,000 | thousands by filing date | |
| PLANET LABS PBC | 72703X114 | *W EXP 12/06/202 | 10,000 | $19,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 27,518 | $16,000 | thousands by filing date | |
| ZIOPHARM ONCOLOGY INC | 98973P101 | COM | 10,000 | $11,000 | thousands by filing date | |
| LANDSEA HOMES CORP | 51509P111 | *W EXP 01/08/202 | 17,000 | $3,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-22-000540 | this filing | 2022-02-14 | acceptance time not in the bulk data set |